Editor's Choice for June 2016
29 Jun 2016
Editor's Choice for June 2016
Results from the EURO-SKI cessation trial of TKIs in CML
Mutations associated with imatinib response in CML
Latest in precision cancer medicine
Specific mutations in leukaemia patients' blood predicts survival
Causes and consequences of microRNA dysregulation in cancer
Sequencing multiple myeloma reveals a complex landscape of genetic lesions
Results from SCHOLAR-1 trial for DLBCL patients
Super-enhancer analysis reveals subtypes in AML and MDS
PD-1 enhances elotuzumab efficacy
Novel therapies for older patients with AML and MDS
Better screening programmes needed for haematological malignancies such as leukaemia